Theriva Biologics TOVX
NYSE TOVX
$0.19 -0.01 (-3.30%)
As of: Oct 22, 2026 · 3:59 PM EDT

Theriva Biologics (TOVX) Tax Provisions (2022 - 2023)

Updated

Theriva Biologics' Tax Provisions was -$424,000 in Q4 2023, compared with -$558,000 a year earlier.

Analysis

Theriva Biologics (TOVX) Tax Provisions (2022 - 2023) Analysis & Trends

For FY2023, Tax Provisions at Theriva Biologics came in at -$1.64 million.

  • In earlier years, Tax Provisions was -$1.43 million in FY2022.
  • Quarterly Tax Provisions has moved between -$558,000 (Q4 2022) and -$330,000 (Q1 2023) over five years.
  • Per Business Quant data, TOVX's Tax Provisions in the three quarters before Q4 2023 was -$527,000 (Q3 2023), -$359,000 (Q2 2023) and -$330,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -176.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 662.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 291.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 242.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -407.00 Mn
10 Theriva Biologics 8.72 Mn -37.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -424,000.00
Sep 30, 2023 -527,000.00
Jun 30, 2023 -359,000.00
Mar 31, 2023 -330,000.00
Dec 31, 2022 -558,000.00
Sep 30, 2022 -335,000.00
Jun 30, 2022 -532,000.00
API Access

Theriva Biologics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=TOVX&period=max&api_key=YOUR_API_KEY